Propel Bio Management »

Abeona Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.3M 1.2M 4.24

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Abeona Therapeutics

Nantahala Capital Management
Suvretta Capital Management
Vanguard Group
Rosalind Advisors
Western Standard
Laurion Capital Management
Propel Bio Management
683 Capital Management
Citigroup
Morgan Stanley
Ikarian Capital
BlackRock
Geode Capital Management
BlackRock
Simplify Asset Management

View all funds holding Abeona Therapeutics